|
|||||
|
|
Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis |
|
| Authors: | Lawrence Anderson MD FACP George J. Schmieder DO W. Philip Werschler MD Eduardo H. Tschen MD Mark R. Ling MD PhD Dow B. Stough MD Janelle Katsamas |
| Affiliation: | aDermatology Associates of Tyler, Tyler, Texas;bPark Avenue Dermatology, PA, Orange Park, Florida;cPremier Clinical Research, Spokane, Washington;dAcademic Dermatology Associates, Albuquerque, New Mexico;eMedaPhase, Inc., Newnan, Georgia;fBurk Pharmaceutical Research, Hot Springs, Arkansas;gPeplin Ltd, Brisbane, Australia |
| Abstract: | |
| Keywords: | Abbreviations: AE, adverse event AK, actinic keratosis 5-FU, 5-fluorouracil GSR, global severity rating LSR, local skin response SCC, squamous cell carcinoma |
| 本文献已被 ScienceDirect 等数据库收录！ | |